Risk factors for amyloid positivity in older people reporting significant memory concern

ObjectiveThe goal of this study is to identify risk factors for the presence of amyloid accumulation in the brains of patients reporting subjective cognitive decline (SCD). Identifying such risk factors will help better identify patients who ought to receive neuroimaging studies to confirm plaque presence and begin intervention, as well as enhancing the study of the pathogenesis of Alzheimer's disease.MethodsNinety-nine SCD participants (72.2 ± 5.6 years, 57.6% female) from the Alzheimer's Disease Neuroimaging Initiative (ADNI) underwent florbetapir PET. Logistic regression analysis was conducted to examine the relationship between the presence of an increased amyloid signal (amyloid positivity) and several potential risk factors, including: demographics, APOE ε4 genotype, family history of dementia, history of hypertension, history of cigarettes smoking, cognitive function and depressive symptoms.ResultsBeing female was a significant risk factor for amyloid positivity (OR = 4.915, 95% CI = 1.709–14.139), as was being an APOE ε4 carrier (OR = 2.985, 95% CI = 1.084–8.219) and having a history of cigarette smoking (OR = 4.091, 95% CI = 1.483–11.285).ConclusionOur study demonstrates that female gender, APOE ε4 genotype, and history of cigarettes smoking are associated with amyloid positivity in patients with SCD.